<SEC-DOCUMENT>0001214659-22-004543.txt : 20220331
<SEC-HEADER>0001214659-22-004543.hdr.sgml : 20220331
<ACCEPTANCE-DATETIME>20220331091026
ACCESSION NUMBER:		0001214659-22-004543
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220331
DATE AS OF CHANGE:		20220331
EFFECTIVENESS DATE:		20220331

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELI LILLY & Co
		CENTRAL INDEX KEY:			0000059478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				350470950
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06351
		FILM NUMBER:		22789460

	BUSINESS ADDRESS:	
		STREET 1:		LILLY CORPORATE CTR
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285
		BUSINESS PHONE:		3172762000

	MAIL ADDRESS:	
		STREET 1:		LILLY CORPORATE CENTER
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LILLY ELI & CO
		DATE OF NAME CHANGE:	19941024

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Legal & General Investment Management America Inc
		CENTRAL INDEX KEY:			0001559265
		IRS NUMBER:				208058531
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		71 SOUTH WACKER DRIVE
		STREET 2:		SUITE 800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		773-867-1650

	MAIL ADDRESS:	
		STREET 1:		71 SOUTH WACKER DRIVE
		STREET 2:		SUITE 800
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>s325220px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="lgimamerica.jpg" ALT="">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTICE OF EXEMPT SOLICITATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF REGISTRANT: Eli Lilly &amp; Co. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF PERSON RELYING ON EXEMPTION: </B>Legal &amp; General Investment
Management America, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ADDRESS OF PERSON RELYING ON EXEMPTION: </B>71 South Wacker Drive,
Suite 800, Chicago, IL 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated
under the Securities Exchange Act of 1934.&nbsp;Submission is not required of this filer under the terms of the Rule, but is made voluntarily.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To:</B></FONT></TD>
    <TD STYLE="width: 94%; font-size: 10pt; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli Lilly &amp; Co. Shareholders</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; color: #333333; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subject:</B></FONT></TD>
    <TD STYLE="font-size: 10pt; color: #333333; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder Proposal for Independent Board Chair (Item #7) </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:</B></FONT></TD>
    <TD STYLE="font-size: 10pt; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Hoeppner, Head of US Stewardship and Sustainable Investments,
    LGIM America</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-indent: -0.6in">&lt;John.Hoeppner@lgima.com&gt;</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to vote FOR an INDEPENDENT BOARD
CHAIR (Item #7) at the Eli Lilly &amp; Co. (&ldquo;Eli Lilly&rdquo; or the &ldquo;Company&rdquo;) stockholder meeting on May 2, 2022.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting for the proposal to require the appointment
or an independent board chair will improve accountability and oversight of material risks at Eli Lilly. A structure where the CEO runs
the business and is accountable to a board led by an independent chair is in the best interests of the Company&rsquo;s shareholders for
the following reasons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Eliminates Structural Conflicts of Interest
in Dual Role</U>. The CEO of the Company should not be his or her own boss. An independent board chair eliminates this structural conflict
of interest and clarifies where the authority of the CEO ends, and responsibility of the independent board members begins. Further, management
of a complex global pharmaceutical company is a full-time job. It is unrealistic &ndash; and needlessly complicated &ndash; to expect
one person to perform well as CEO on top of his or her responsibilities for providing rigorous board oversight. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Board Failure to Oversee Material Risks</U>.
In light of potentially material legal, regulatory, financial and reputational risks, as well as possible controversies and legal challenges
that may face the Company, we are concerned that the board is not providing sufficiently robust oversight of the Company&rsquo;s culture,
strategy, and risk management. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Absence of Important Governance Provisions</U>.
An independent board chair would be especially useful at Eli Lilly, as its shareholders do not have common &ndash; yet critical &ndash;
investor rights that provide additional accountability when it comes to, for example, the right to annually (re)elect all directors since
such an amendment requires the approval of 80% of the outstanding shares according to the Company&rsquo;s articles of incorporation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eli Lilly references a study from EY on corporate
governance to back up their views on board independence, stating that only 36% of companies in the S&amp;P500 have an independent chair.
However, the study also states that 57% of those companies in the S&amp;P 500 have a separate chair and CEO<SUP>1</SUP>. Therefore, the
majority of the S&amp;P500 actually have a separate chair and CEO. Further, if we compare the presence of combined chair and CEO positions
in the S&amp;P500 to another Anglo-Saxon index like the UK FTSE100, we only find one company that has a combined chair and CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> https://assets.ey.com/content/dam/ey-sites/ey-com/en_us/topics/board-matters/ey-2201-3960147-dec-2021-cgbtn-final-score.pdf</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not suggesting that there is a required
&ldquo;one-size-fits-all&rdquo; approach to board leadership; however, we are suggesting that there are governance best practices that
need to be applied to ensure good risk management. Indeed, it is the role of the board to evaluate and implement the leadership structure
best suited for the company&rsquo;s success, but there is a clear bias and conflict of interest when the leader of the company and the
chair of the board are the same person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management suggests that &ldquo;having one individual
serve as both chair and CEO provides the board with deep insights to drive long-term strategy and execution and allows consistent communication
throughout the company.&rdquo; And that this is &ldquo;vital to [the company&rsquo;s] innovative research and business&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There is no reason why the CEO&rsquo;s insights
and communication cannot or should not be shared with an independent board. The difference, should the shareholder proposal be adopted,
is that those insights will then be subjected to review and oversight by a board led by an independent chair, rather than by a board led
by the same person whose insights are being considered.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted in the shareholder proposal, according
to a 2019 survey of over 700 directors by PricewaterhouseCoopers (PwC), 57% of directors surveyed who sit on a board with a combined chair
and CEO indicated that it is difficult to voice dissent, compared to 43% overall.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although Eli Lilly has an independent lead director,
which we welcome, the lead director is elected on an annual basis which undermines long-term consistency. Further, the lead director is
elected by and among the independent directors of the board which prevents the shareholders from holding the appointed director accountable
as lead independent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LGIM<SUP>2</SUP> believes that having an independent
board chair is in the best interest of the Company and its shareholders. This is essential to ensure they perform their board functions
effectively and free from any conflicts of interest or structural bias<SUP>3</SUP>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A CEO that also serves as chair can ultimately
weaken the board&rsquo;s oversight of management by wielding influence over the board and its agenda<SUP>4</SUP>. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The chair is expected to regularly challenge
the actions of management, therefore suggesting that the current CEO and chair is capable of being their own boss and critiquing their
own management style is not only a conflict of interest but also a huge organizational risk.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A separate chair and CEO is essential for a balance
of authority and responsibility that is in both the company&rsquo;s and investors&rsquo; best interests. The perceived advantages of concentrating
decision-making power in the hands of a single individual&nbsp;do not outweigh the risks.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">One of the major functions of the board chair is to oversee the actions of
the management team; they are expected to act as a counter-power and constructively challenge the executive directors<SUP>5</SUP>. When
the chair and CEO have a combined role, the CEO is essentially being overseen by themselves. It is not reasonable to assume that the chair
can effectively and un-biasedly critique and challenge themselves and their decision making as CEO.</FONT></TD></TR></TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Symbol; margin: 0pt 0">_____________________________</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: windowtext"><SUP>2</SUP></FONT>
Unless otherwise stated, references herein to &ldquo;LGIM&rdquo;, &ldquo;we&rdquo; and &ldquo;us&rdquo; are meant to capture the global
conglomerate that includes Legal &amp; General Investment Management America, Inc. (a U.S. SEC registered investment adviser), which is
the entity that filed the Shareholder Proposal, as well as Legal &amp; General Investment Management Ltd. (a U.K. FCA authorized adviser),
LGIM International Limited (a U.S. SEC registered investment adviser and U.K. FCA authorized adviser), and Legal &amp; General Investment
Management Asia Limited (a Hong Kong SFC registered adviser). The LGIM Stewardship Team acts on behalf of all such locally authorized
entities.</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: windowtext"><SUP>3</SUP></FONT>
h<FONT STYLE="font-size: 10pt">ttps://www.lgim.com/landg-assets/lgim/_document-library/capabilities/a-guide-to-the-nomination-of-board-chairs.pdf</FONT></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: windowtext"><SUP>4</SUP></FONT>
https://www.cii.org/independent_board#:~:text=Having%20an%20independent%20chair%20helps,the%20board's%20oversight%20of%20management</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: windowtext"><SUP>5</SUP></FONT>
h<FONT STYLE="font-size: 10pt">ttps://www.lgim.com/landg-assets/lgim/_document-library/capabilities/separating-the-roles-of-ceo-and-board-chair.pdf</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #333333; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The chair must always adopt a measured approach to ensure they do not act
as an executive, or, conversely, under the influence of the CEO. This is practically impossible in the case of a combined chair and CEO
&ndash; having the same person sitting as both chair and CEO is a clear conflict of interest and has obvious implications when it comes
to decision making. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Last year, 36.3% of shareholders voted in support of a similar proposal
for an independent chair and the previous year 33.9%. Although this does not represent the majority of shareholders, it does reflect the
views of a significant number of shareholders.</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We therefore urge shareholders
to vote FOR Item 7.</B></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>For further information, please contact John Hoeppner
at John.Hoeppner@lgima.com</I></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE FOREGOING INFORMATION MAY
BE DISSEMINATED TO SHAREHOLDERS VIA TELEPHONE, U.S. MAIL, E-MAIL, CERTAIN WEBSITES, AND CERTAIN SOCIAL MEDIA VENUES, AND SHOULD NOT BE
CONSTRUED AS INVESTMENT ADVISE OR AS A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. THE COST OF DISSEMINATING THE FOREGOING INFORMATION
TO SHAREHOLDERS IS BEING BORNE ENTIRELY BY ONE OR MORE OF THE CO-FILERS.</B></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY CARDS WILL NOT BE ACCEPTED
BY ANY FILER. PLEASE DO NOT SEND YOUR PROXY TO ANY FILER. TO VOTE YOUR PROXY, PLEASE FOLLOW THE INSTRUCTIONS ON YOUR PROXY CARD.</B></P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #333333; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #333333; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lgimamerica.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lgimamerica.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( '@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M'Q./P6*I3Q=>&99?B88;!47257%UJE/!UHTZ.'A4G.K4I))1;DOC/V[&0?\
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M9\>/ ?Q3O_&'PO\ 'NA7IOKJ*TT3QUX?TK1/&UQ\//%?A/QY:MX9U;2_"OQ
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M (CUO4]-^)>I^&OLVEZ5HO@?POH7P\TF37?%D^HP:],WAZXT8HH _I_HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
